We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.34B
AUM Growth
+$63.1M
Cap. Flow
-$11.2M
Cap. Flow %
-0.84%
Top 10 Hldgs %
31.36%
Holding
203
New
11
Increased
60
Reduced
76
Closed
6

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$2M
2
HXL icon
Hexcel
HXL
+$1.65M
3
GILD icon
Gilead Sciences
GILD
+$1.07M
4
DVN icon
Devon Energy
DVN
+$1.05M
5
MTB icon
M&T Bank
MTB
+$531K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$4.81M
2
MSFT icon
Microsoft
MSFT
+$2.13M
3
PYPL icon
PayPal
PYPL
+$1.92M
4
USB icon
US Bancorp
USB
+$934K
5
ADSK icon
Autodesk
ADSK
+$842K

Sector Composition

Rank Sector Weight
1 Technology 28.13%
2 Healthcare 14.71%
3 Financials 12.99%
4 Industrials 12.74%
5 Consumer Staples 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BC icon
26
Brunswick
BC
$5.23B
$20.6M 1.54%
215,735
-2,442
-1% -$224K
ALB icon
27
Albemarle
ALB
$13.3B
$20.5M 1.53%
140,001
-2,308
-2% -$370K
ZBH icon
28
Zimmer Biomet
ZBH
$18.7B
$20.4M 1.53%
131,447
-1,077
-0.8% -$167K
CACI icon
29
CACI
CACI
$10.9B
$20.4M 1.53%
82,784
-903
-1% -$216K
CB icon
30
Chubb
CB
$141B
$20.1M 1.51%
127,461
+1,049
+0.8% +$169K
RTX icon
31
RTX Corp
RTX
$293B
$19M 1.42%
246,057
+27,443
+13% +$2M
PG icon
32
Procter & Gamble
PG
$338B
$17M 1.27%
125,644
+1,754
+1% +$229K
JNJ icon
33
Johnson & Johnson
JNJ
$644B
$17M 1.27%
103,368
+1,103
+1% +$178K
PPG icon
34
PPG Industries
PPG
$25.1B
$16.8M 1.26%
112,043
-1,430
-1% -$205K
WLY icon
35
John Wiley & Sons Class A
WLY
$2.82B
$16.5M 1.23%
304,065
-6,878
-2% -$350K
SNY icon
36
Sanofi
SNY
$109B
$15.6M 1.17%
315,862
+2,918
+0.9% +$140K
MTB icon
37
M&T Bank
MTB
$36.5B
$15.5M 1.16%
102,239
+3,599
+4% +$531K
GLW icon
38
Corning
GLW
$109B
$14.7M 1.1%
337,437
-3,180
-0.9% -$122K
CTSH icon
39
Cognizant
CTSH
$25.8B
$13.6M 1.01%
173,544
+5,731
+3% +$443K
AAPL icon
40
Apple
AAPL
$5T
$13.1M 0.98%
107,506
-912
-0.8% -$117K
GILD icon
41
Gilead Sciences
GILD
$165B
$13.1M 0.98%
202,620
+16,640
+9% +$1.07M
CVX icon
42
Chevron
CVX
$382B
$13.1M 0.98%
124,833
+899
+0.7% +$87.8K
FLIR
43
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$12.6M 0.94%
222,797
-4,146
-2% -$225K
HXL icon
44
Hexcel
HXL
$7.99B
$12.3M 0.92%
218,818
+31,308
+17% +$1.65M
NVS icon
45
Novartis
NVS
$299B
$11M 0.83%
129,115
-2,203
-2% -$198K
TMO icon
46
Thermo Fisher Scientific
TMO
$215B
$10.1M 0.75%
22,044
-212
-1% -$101K
REGN icon
47
Regeneron Pharmaceuticals
REGN
$73.3B
$8.78M 0.66%
18,562
+807
+5% +$393K
XOM icon
48
ExxonMobil
XOM
$655B
$8.73M 0.65%
156,435
-4,570
-3% -$240K
BRK.A icon
49
Berkshire Hathaway Class A
BRK.A
$1.1T
$8.49M 0.63%
22
VOO icon
50
Vanguard S&P 500 ETF
VOO
$963B
$7.76M 0.58%
21,303

Similar funds

Grandfield & Dodd's Q1 2021 Portfolio in Review

As of Q1 2021, Grandfield & Dodd held 203 positions worth $1.34B, up 5% from $1.27B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q1 2021 filing shows 11 new, 60 increased, 76 reduced and 6 closed positions. Its largest new stake was Lowe's Companies: 1,836 shares worth $350K. The largest sale was UnitedHealth, an estimated $4.81M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q1 2021 buy was Lowe's Companies: 1,836 shares worth $350K.
  • Grandfield & Dodd added most to RTX Corp in Q1 2021, an estimated $2M increase.
  • Grandfield & Dodd's biggest Q1 2021 reduction was Microsoft, cutting an estimated $2.13M.
  • Grandfield & Dodd fully exited UnitedHealth in Q1 2021, selling an estimated $4.81M.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $1.34B portfolio in Q1 2021.
  • Grandfield & Dodd opened 11 new positions and closed 6 in Q1 2021.
  • Grandfield & Dodd's portfolio value rose 5% quarter-over-quarter to $1.34B.

Based on Grandfield & Dodd's 13F filing for Q1 2021, filed 22 Apr 2021.